|
SIRT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27500000002279E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.83479999988401E-07 |
| Normal-vs-Stage2 |
3.255600E-02 |
| Normal-vs-Stage3 |
2.325900E-02 |
| Normal-vs-Stage4 |
4.512200E-01 |
| Stage1-vs-Stage2 |
3.404000E-01 |
| Stage1-vs-Stage3 |
2.856000E-01 |
| Stage1-vs-Stage4 |
2.188400E-01 |
| Stage2-vs-Stage3 |
9.856200E-01 |
| Stage2-vs-Stage4 |
6.059800E-01 |
| Stage3-vs-Stage4 |
5.937200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95799999991308E-07 |
| Normal-vs-AfricanAmerican |
1.396350E-02 |
| Normal-vs-Asian |
4.493800E-01 |
| Caucasian-vs-AfricanAmerican |
1.032440E-01 |
| Caucasian-vs-Asian |
4.363800E-01 |
| AfricanAmerican-vs-Asian |
8.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65520000430897E-08 |
| Normal-vs-Female |
1.391000E-01 |
| Male-vs-Female |
1.904840E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.218790E-03 |
| Normal-vs-Extreme_Weight |
2.51649999727377E-08 |
| Normal-vs-Obese |
1.864150E-02 |
| Normal-vs-Extreme_Obese |
3.49629999996104E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.700600E-01 |
| Normal_Weight-vs-Obese |
2.564200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.555000E-01 |
| Extreme_Weight-vs-Obese |
8.221800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.005000E-01 |
| Obese-vs-Extreme_Obese |
6.335600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.773800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.217800E-03 |
| Normal-vs-Age(61-80Yrs) |
7.39490002565901E-09 |
| Normal-vs-Age(81-100Yrs) |
9.511299999998E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.759600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.193790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.708200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.257600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.163410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.315200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11120000001463E-06 |
| Normal-VS-Type2 PRCC |
5.11909999945104E-07 |
| Normal-VS-KIRP CIMP |
2.934600E-01 |
| Normal-VS-Unclassified PRCC |
5.069700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.926000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.915500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.534400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.153400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.065750E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.434500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.64619999538141E-08 |
| Normal-vs-N1 |
7.894000E-01 |
| Normal-vs-N2 |
2.036100E-02 |
| N0-vs-N1 |
2.239800E-03 |
| N0-vs-N2 |
7.246800E-01 |
| N1-vs-N2 |
2.457600E-01 |
|
|
